Genetic Resistance Determinants in Clinical Genomes.

Antibiotics (Basel)

Department of Project Manager, Universidad Internacional Iberoamericana, Campeche 24560, Mexico.

Published: May 2022

AI Article Synopsis

  • Antimicrobial-resistant bacteria, especially in healthcare settings, are a growing public health concern, with the ESKAPE group being particularly problematic due to its multi-drug resistant species.
  • Recent studies focus on a closely related species of the ESKAPE group, noting a rise in its isolation and multi-drug resistance.
  • This research analyzes the genomes of five isolates from a Spanish hospital, revealing genes for β-lactam resistance and novel mutations linked to colistin resistance, underscoring the importance of such comparative genomic studies.

Article Abstract

Antimicrobial-resistant pathogenic bacteria are an increasing problem in public health, especially in the healthcare environment, where nosocomial infection microorganisms find their niche. Among these bacteria, the genus which belongs to the ESKAPE pathogenic group harbors different multi-drug resistant (MDR) species that cause human nosocomial infections. Although has always attracted more interest, the close-related species is the object of more study due to the increase in its isolation and MDR strains. In this work, we present the genomic analysis of five clinically isolated strains from a Spanish hospital, with special attention to their genetic resistance determinants and plasmid structures. All the strains harbored different genes related to β-lactam resistance, as well as different MDR efflux pumps. We also found and described, for the first time in this species, point mutations that seem linked with colistin resistance, which highlights the relevance of this comparative analysis among the pathogenic species isolates.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137642PMC
http://dx.doi.org/10.3390/antibiotics11050676DOI Listing

Publication Analysis

Top Keywords

genetic resistance
8
resistance determinants
8
determinants clinical
4
clinical genomes
4
genomes antimicrobial-resistant
4
antimicrobial-resistant pathogenic
4
pathogenic bacteria
4
bacteria increasing
4
increasing problem
4
problem public
4

Similar Publications

Bladder cancer (BLCA) genomic profiling has identified molecular subtypes with distinct clinical characteristics and variable sensitivities to frontline therapy. BLCAs can be categorized into luminal or basal subtypes based on their gene expression. We comprehensively characterized nine human BLCA cell lines (UC3, UC6, UC9, UC13, UC14, T24, SCaBER, RT4V6 and RT112) into molecular subtypes using orthotopic xenograft models.

View Article and Find Full Text PDF

Teaching evaluation at many institutions is insufficient to support, recognize, and reward effective teaching. We developed a long-term intervention to support science, technology, engineering, and mathematics (STEM) department heads in advancing teaching evaluation practices. We describe the intervention and systematically investigate its impact on departmental practices within a research-intensive university.

View Article and Find Full Text PDF

Widespread anthelmintic resistance has complicated the management of parasitic nematodes. Resistance to the benzimidazole (BZ) drug class is nearly ubiquitous in many species and is associated with mutations in beta-tubulin genes. However, mutations in beta-tubulin alone do not fully explain all BZ resistance.

View Article and Find Full Text PDF

Objective: This study aimed to evaluate the occurrence of methicillin-resistant Staphylococcus aureus (MRSA) at the University Hospital Olomouc (UHO) over a 10-year period (2013-2022).

Material And Methods: Data was obtained from the ENVIS LIMS laboratory information system (DS Soft, Czech Republic, Olomouc) of the Department of Microbiology, UHO, for the period 1/1/2013-31/12/2022. Standard microbiological procedures using the MALDI-TOF MS system (Biotyper Microflex, Bruker Daltonics) were applied for the identification.

View Article and Find Full Text PDF

5-FU is a widely used chemotherapy drug for esophageal carcinomas, but therapy failure has been observed in 5-FU-resistant patients. Overcoming this resistance is a significant challenge in cancer treatment, requiring identifying and targeting important resistance mechanisms. PYGO2 expression is crucial in developing resistance to various chemotherapy drugs.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!